VEGFA and esophageal cancer: NETs possess the capacity to degrade the ECM via proteases (e.g., MMP9, NE), releasing vascular endothelial growth factor (VEGF) and platelet-derived growth factors (PFs) to enhance the invasive potential of esophageal cancer cells and facilitate angiogenesis [87].